Surgery Partners, Inc.
SGRY
$21.22
$0.130.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.52% | 9.96% | 8.55% | 7.10% | 8.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.52% | 9.96% | 8.55% | 7.10% | 8.03% |
| Cost of Revenue | 13.02% | 9.77% | 6.67% | 4.96% | 6.69% |
| Gross Profit | 15.15% | 10.56% | 14.96% | 14.50% | 12.63% |
| SG&A Expenses | 14.72% | -3.96% | 19.49% | 16.62% | 18.30% |
| Depreciation & Amortization | 29.21% | 28.47% | 9.36% | -2.48% | 2.87% |
| Other Operating Expenses | -166.67% | -20.97% | -2.94% | 42.00% | 54.82% |
| Total Operating Expenses | 13.44% | 9.89% | 7.45% | 5.42% | 7.51% |
| Operating Income | 14.01% | 10.34% | 14.95% | 17.14% | 11.08% |
| Income Before Tax | 8.96% | 8.74% | 53.49% | 149.39% | 22.39% |
| Income Tax Expenses | 44,966.67% | 450.00% | 121.69% | -72.06% | -101.29% |
| Earnings from Continuing Operations | -90.76% | -5.45% | 47.04% | 248.90% | 55.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -22.69% | -13.82% | -14.56% | -15.10% | -3.95% |
| Net Income | -1,312.61% | -76.68% | 37.87% | 100.65% | 78.21% |
| EBIT | 14.01% | 10.34% | 14.95% | 17.14% | 11.08% |
| EBITDA | 17.38% | 14.39% | 13.66% | 12.34% | 9.16% |
| EPS Basic | -1,293.51% | -51.43% | 52.05% | 100.53% | 83.50% |
| Normalized Basic EPS | 94.94% | 103.23% | 111.58% | 106.39% | 101.49% |
| EPS Diluted | -1,261.02% | -49.95% | 51.86% | 100.22% | 83.22% |
| Normalized Diluted EPS | 83.33% | 103.25% | 111.61% | 106.52% | 101.60% |
| Average Basic Shares Outstanding | 0.41% | 5.33% | 14.02% | 24.28% | 36.65% |
| Average Diluted Shares Outstanding | 0.08% | 4.96% | 13.59% | 24.69% | 36.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |